Target intelligence / Profile preview

Matrin-3 (MATR3)

Target
MATR3
Molecular classification
Other, RNA-binding protein, DNA-binding protein, Nuclear matrix protein
01

Overview

Matrin-3 is a highly conserved 125 kDa protein encoded by the MATR3 gene, widely expressed in human tissues with highest levels in the brain[1][4]. Localized to the nuclear matrix, it is integral to nuclear architecture and contains two RNA recognition motifs and two C2H2 zinc finger domains, allowing it to bind both RNA and DNA[1][4][7]. Matrin-3 is involved in diverse nuclear processes, including RNA stabilization and processing, DNA binding, chromatin organization, gene expression regulation, and DNA repair[2][3][4][7]. Pathogenic mutations in MATR3 are linked to familial forms of amyotrophic lateral sclerosis and distal myopathy[5][6][7]. The protein is not a canonical therapeutic target such as a receptor, ion channel, or enzyme, but it plays critical regulatory roles in normal physiology and disease through its effects on nuclear structure and gene regulation[1][2][3][4][7].

Other names
Matrin 3Nuclear matrix protein Matrin-3NMP-180
02

Biological functions

RNA binding and processingmRNA stabilizationDNA bindingChromatin organizationRegulation of gene expressionDNA repairTranscriptional regulationCell differentiationCell survival
03

Disease associations

Amyotrophic lateral sclerosis (ALS)Frontotemporal dementia (FTD)Distal myopathyNeurodegenerative disease
04

Safety considerations

Mutations may be associated with neurodegenerative diseases, including ALS and distal myopathypossible toxicity in neurons due to aggregation or mislocalization
05

Biomarkers

Mutations in MATR3 (e.g., Ser85Cys) as biomarkers for familial ALS and distal myopathy

Beyond the preview

Go deeper on Matrin-3 (MATR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrin-3 (MATR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call